← Open Payments lookup

ANDRA BRIGHT: Open Payments

NPI 1952903650 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$150 in 8 payments from 7 companies in 2025. Trend: 2023 $1,831 · 2024 $944 · 2025 $150

Food & beverage: $150
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.2$41
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Alkermes, Inc.1$19
Janssen Pharmaceuticals, Inc1$19
ABBVIE INC.1$16
Teva Pharmaceuticals USA, Inc.1$16
E.R. Squibb & Sons, L.L.C.1$16

Products named: INGREZZA, CAPLYTA, ARISTADA, INVEGA SUSTENNA, VRAYLAR, UZEDY, COBENFY.

Industry payments across AL — which companies pay providers there.